FI955525A - Pintamodifioituja, biologisesti yhteensopivia kalvoja - Google Patents

Pintamodifioituja, biologisesti yhteensopivia kalvoja Download PDF

Info

Publication number
FI955525A
FI955525A FI955525A FI955525A FI955525A FI 955525 A FI955525 A FI 955525A FI 955525 A FI955525 A FI 955525A FI 955525 A FI955525 A FI 955525A FI 955525 A FI955525 A FI 955525A
Authority
FI
Finland
Prior art keywords
pct
surface modified
sec
date
biocompatible films
Prior art date
Application number
FI955525A
Other languages
English (en)
Swedish (sv)
Other versions
FI955525A0 (fi
Inventor
Elisabeth Scholander
Andrzej Werynski
Andrzej Jozwiak
Olle Larm
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of FI955525A publication Critical patent/FI955525A/fi
Publication of FI955525A0 publication Critical patent/FI955525A0/fi

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0081—After-treatment of organic or inorganic membranes
    • B01D67/0093—Chemical modification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002—Organic membrane manufacture
    • B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/0011—Casting solutions therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002—Organic membrane manufacture
    • B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/0016—Coagulation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002—Organic membrane manufacture
    • B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/0016—Coagulation
    • B01D67/00165—Composition of the coagulation baths
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2323/00—Details relating to membrane preparation
    • B01D2323/08—Specific temperatures applied
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2323/00—Details relating to membrane preparation
    • B01D2323/12—Specific ratios of components used

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Reciprocating, Oscillating Or Vibrating Motors (AREA)
FI955525A 1993-05-19 1995-11-16 Pintamodifioituja, biologisesti yhteensopivia kalvoja FI955525A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO931809A NO931809L (no) 1993-05-19 1993-05-19 Hemofilter
PCT/NO1994/000088 WO1994026399A1 (en) 1993-05-19 1994-05-09 Surface modified biocompatible membranes

Publications (2)

Publication Number Publication Date
FI955525A true FI955525A (fi) 1995-11-16
FI955525A0 FI955525A0 (fi) 1995-11-16

Family

ID=19896100

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955525A FI955525A0 (fi) 1993-05-19 1995-11-16 Pintamodifioituja, biologisesti yhteensopivia kalvoja

Country Status (14)

Country Link
US (1) US5840190A (fi)
EP (1) EP0699103B1 (fi)
JP (1) JPH08510166A (fi)
AT (1) ATE254953T1 (fi)
AU (1) AU672708B2 (fi)
BR (1) BR9406410A (fi)
CA (1) CA2162495A1 (fi)
DE (1) DE69433356T2 (fi)
DK (1) DK0699103T3 (fi)
ES (1) ES2211881T3 (fi)
FI (1) FI955525A0 (fi)
NO (1) NO931809L (fi)
PT (1) PT699103E (fi)
WO (1) WO1994026399A1 (fi)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304220A (en) * 1991-07-03 1994-04-19 Maginot Thomas J Method and apparatus for implanting a graft prosthesis in the body of a patient
US20020156523A1 (en) * 1994-08-31 2002-10-24 Lilip Lau Exterior supported self-expanding stent-graft
US6331188B1 (en) * 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
DE19514104C2 (de) * 1995-04-13 1997-05-28 Behringwerke Ag Beschichtung für in den Blutstrom oder in das Gewebe des menschlichen Körpers einbringbares Biomaterial
BR9709867A (pt) * 1996-06-20 2000-01-11 Sulzer Vascutek Ltda Dispositivo para a retenção uma prótese em uma passagrm do corpo dispositivo para a fixação de uma prótese em uma superfìcie interna de uma passagem do corpo, dispositivo protético, prótese e processo para fixar um dispositivo protético, para reparar um vaso e para inserir uma prótese em uma passagem do corpo.
US6551350B1 (en) * 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
FR2772639B1 (fr) * 1997-12-24 2000-02-04 Hospal Ind Utilisation d'un polymere neutre ou cationique pour prevenir l'activation de la phase contact du sang ou du plasma en contact avec une membrane semi-permeable
US6221425B1 (en) * 1998-01-30 2001-04-24 Advanced Cardiovascular Systems, Inc. Lubricious hydrophilic coating for an intracorporeal medical device
FR2804328B1 (fr) * 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
US6991528B2 (en) 2000-02-17 2006-01-31 Applied Materials, Inc. Conductive polishing article for electrochemical mechanical polishing
US7029365B2 (en) * 2000-02-17 2006-04-18 Applied Materials Inc. Pad assembly for electrochemical mechanical processing
US7678245B2 (en) 2000-02-17 2010-03-16 Applied Materials, Inc. Method and apparatus for electrochemical mechanical processing
US7670468B2 (en) 2000-02-17 2010-03-02 Applied Materials, Inc. Contact assembly and method for electrochemical mechanical processing
US6848970B2 (en) 2002-09-16 2005-02-01 Applied Materials, Inc. Process control in electrochemically assisted planarization
US7687437B2 (en) 2001-07-13 2010-03-30 Nanosphere, Inc. Method for immobilizing molecules onto surfaces
US7297553B2 (en) * 2002-05-28 2007-11-20 Nanosphere, Inc. Method for attachment of silylated molecules to glass surfaces
US20050287560A1 (en) * 2001-07-13 2005-12-29 Nanosphere, Inc. Method for preparing substrates having immobilized molecules and substrates
US7407668B2 (en) * 2002-01-24 2008-08-05 Boston Scimed, Inc. Medical articles having enzymatic surfaces for localized therapy
SE527054C2 (sv) * 2002-04-23 2005-12-13 Gambro Lundia Ab Förfarande för framställning av ett regioselektivt membran
DE102004008219B3 (de) * 2004-02-19 2005-10-27 Membrana Gmbh Integral asymmetrische Membran, Verfahren zu ihrer Herstellung und ihre Verwendung
EP1818066A4 (en) * 2004-11-05 2011-08-31 Kaneka Corp METHOD OF MODIFYING MATERIAL TO BE IN CONTACT WITH BLOOD, AND MATERIAL TO BE IN CONTACT WITH MODIFIED BLOOD SO NOT TO ACTIVATE GRANULOCYTES
US9173989B2 (en) 2005-12-13 2015-11-03 Exthera Medical Corporation Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
US20080135481A1 (en) * 2006-12-06 2008-06-12 General Electric Company Polyarylethernitrile hollow fiber membranes
US7681741B2 (en) * 2006-12-15 2010-03-23 General Electric Company Functional polyarylethers
US7977451B2 (en) * 2006-12-15 2011-07-12 General Electric Company Polyarylether membranes
US7669720B2 (en) * 2006-12-15 2010-03-02 General Electric Company Functional polyarylethers
US20110168631A1 (en) * 2006-12-15 2011-07-14 General Electric Company Methods and apparatuses for water filtration using polyarylether membranes
AU2008265838A1 (en) * 2007-06-18 2008-12-24 Exthera Medical Llc Device and method for restoration of the condition of blood
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
CN100548456C (zh) * 2007-08-29 2009-10-14 浙江大学 一种亲和性丙烯腈基共聚物超细纤维膜的制备方法和应用
US20090069790A1 (en) * 2007-09-07 2009-03-12 Edward Maxwell Yokley Surface properties of polymeric materials with nanoscale functional coating
US8962097B1 (en) 2007-09-07 2015-02-24 Edward Maxwell Yokley Surface properties of polymeric materials with nanoscale functional coating
DE102008000220A1 (de) * 2008-02-01 2009-08-13 ASCALON Gesellschaft für Innovation in der Medizintechnik m.b.H. Hohlfaser-Separationsmembranen und Verfahren zu ihrer Herstellung
US20100222489A1 (en) * 2009-02-27 2010-09-02 Jiang Dayue D Copolymer composition, membrane article, and methods thereof
WO2011068897A1 (en) 2009-12-01 2011-06-09 Exthera Medical, Llc Method for removing cytokines from blood with surface immobilized polysaccharides
FR2960783B1 (fr) 2010-06-04 2012-07-27 Ass Pour Les Transferts De Technologies Du Mans Membrane fonctionnalisee pour chambre d'encapsulation de cellules produisant au moins une substance d'interet therapeutique et organe bioartificiel comprenant une telle membrane
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
DK2861273T3 (da) 2012-06-13 2017-11-27 Exthera Medical Corp Anvendelse af heparin og kulhydrater til behandling af cancer.
JP6648009B2 (ja) 2013-06-24 2020-02-14 エクステラ・メディカル・コーポレーション マンノース被覆基材を含有する血液濾過システム
BR112016009827B1 (pt) 2013-11-08 2021-10-26 Exthera Medical Corporation Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit
CN105813626B (zh) * 2013-12-09 2019-05-07 株式会社Lg生活健康 含有碳二亚胺类化合物的组合物
BR112016024569B1 (pt) 2014-04-24 2023-01-03 Exthera Medical Corporation Método ex vivo para remover bactérias de uma amostra retirada de um indivíduo que é suspeito de estar infectado com a mesma
BR112017004059A2 (pt) 2014-09-22 2017-12-05 Exthera Medical Corp dispositivo de hemoperfusão utilizável
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
EP3680005A1 (en) * 2019-01-10 2020-07-15 Gambro Lundia AB Membrane with immobilized anticoagulant and process for producing same
EP3981505A1 (en) 2020-10-12 2022-04-13 Gambro Lundia AB Membrane with immobilized anticoagulant and process for producing same
CN115120787B (zh) * 2022-06-30 2023-06-23 上海翊科聚合物科技有限公司 一种血液透析复合膜制备方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441142A (en) * 1966-07-21 1969-04-29 Dow Chemical Co Nonthrombogenic plastic membranes
US3522346A (en) * 1968-05-31 1970-07-28 Research Corp Nonthrombogenic microcapsules
US3616935A (en) * 1970-02-05 1971-11-02 Dow Chemical Co Preparation of antithrombogenic surfaces
US3705084A (en) * 1970-03-18 1972-12-05 Monsanto Co Macroporous enzyme reactor
US4102746A (en) * 1975-08-29 1978-07-25 Amerace Corporation Immobilized proteins
US4702840A (en) * 1982-02-05 1987-10-27 Pall Corporation Charge modified polyamide membrane
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4906375A (en) * 1984-07-14 1990-03-06 Fresenius, Ag Asymmetrical microporous hollow fiber for hemodialysis
US4757014A (en) * 1985-11-08 1988-07-12 Minnesota Mining And Manufacturing Company Immobilization of biologically active protein on a polymeric fibrous support
GB8915974D0 (en) * 1989-07-12 1989-08-31 Gore W L & Ass Uk Hydrophilic semi-permeable ptfe membranes and their manufacture
US5096585A (en) * 1991-01-28 1992-03-17 W. R. Grace & Co.-Conn. Process for preparing protein non-adsorptive microporous polysulfone membranes
US5283186A (en) * 1991-12-31 1994-02-01 Abbott Laboratories Preparation of a compressed membrane containing immobilized biologically acting material
DE4238389A1 (de) * 1992-11-13 1994-05-19 Bayer Ag Verfahren zur Durchführung immundiagnostischer Nachweise
US5476665A (en) * 1994-04-13 1995-12-19 Minnesota Mining And Manufacturing Company Azlactone functional particles incorporated in a membrane formed by solvent phase inversion

Also Published As

Publication number Publication date
ES2211881T3 (es) 2004-07-16
ATE254953T1 (de) 2003-12-15
AU672708B2 (en) 1996-10-10
CA2162495A1 (en) 1994-11-24
US5840190A (en) 1998-11-24
BR9406410A (pt) 1995-12-19
NO931809D0 (no) 1993-05-19
EP0699103A1 (en) 1996-03-06
JPH08510166A (ja) 1996-10-29
DK0699103T3 (da) 2004-04-05
PT699103E (pt) 2004-04-30
AU6816994A (en) 1994-12-12
NO931809L (no) 1994-11-21
EP0699103B1 (en) 2003-11-26
DE69433356D1 (de) 2004-01-08
DE69433356T2 (de) 2004-08-26
WO1994026399A1 (en) 1994-11-24
FI955525A0 (fi) 1995-11-16

Similar Documents

Publication Publication Date Title
FI955525A (fi) Pintamodifioituja, biologisesti yhteensopivia kalvoja
BR9604817A (pt) Eteres perfluoroalquílicos contendo polisiloxana e sua preparação e uso
AU3506893A (en) Use of fullerenes in diagnostic and/or therapeutic agents
ATE151646T1 (de) Biegsamer gummigegenstand mit verbesserten gleiteigenschaften
MX9704828A (es) Una pelicula encogible en agua.
ATE177421T1 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
DK1028707T3 (da) Oftalmiske præparater med forlænget frigivelse og indeholdende vandopløselige medikamenter
NO306698B1 (no) Aktivstoffplaster med kontrollert avgivelse samt fremgangsmåte for fremstilling derav
GR3030858T3 (en) Item of clothing, especially disposable clothing for use once only
GEP20032976B (en) Artificial Peptides Having Surface Activity and Use Thereof in The Preparation of Artificial Surfactant
DE69719931D1 (de) Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
EP0525795A3 (en) Use of fluorinated polyurethanes for the treatment of films or sheets made of cellulose, graphite, mica, kaolin, leather and similar natural materials
DE59610633D1 (de) Medikament, insbesondere zur modulation der immunantwort bei der bekämpfung von viren, tumoren, bakterien und parasiten
ZA981780B (en) The use of levobupivacaine in paediatric surgery
NZ230155A (en) N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions
GB9411009D0 (en) Dialysis fluid
FR2413912A1 (fr) Medicaments a base de substances d'origine foetale et leur procede preparation
ATE209647T1 (de) Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien
SE0301546L (sv) Biokompatibel polymer
NO954644L (no) Overflate-modifiserte biokompatible membraner
NO984965L (no) Komponent B som cicatrisant
SE9403861D0 (sv) Novel medicinal use
ES2116574T3 (es) 4-guanidinobutiramida para mejorar la circulacion de la sangre.
ZA915627B (en) The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties,and vaccines containing same